1. Home
  2. FBNC vs TMDX Comparison

FBNC vs TMDX Comparison

Compare FBNC & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Bancorp

FBNC

First Bancorp

HOLD

Current Price

$66.27

Market Cap

2.7B

Sector

Finance

ML Signal

HOLD

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

HOLD

Current Price

$90.77

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FBNC
TMDX
Founded
1934
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.6B
IPO Year
1995
2019

Fundamental Metrics

Financial Performance
Metric
FBNC
TMDX
Price
$66.27
$90.77
Analyst Decision
Buy
Buy
Analyst Count
4
9
Target Price
$62.25
$148.22
AVG Volume (30 Days)
194.8K
951.4K
Earning Date
04-22-2026
05-05-2026
Dividend Yield
1.67%
N/A
EPS Growth
45.65
382.18
EPS
2.35
0.61
Revenue
$67,623,000.00
$605,494,000.00
Revenue This Year
$37.82
$24.25
Revenue Next Year
$2.30
$18.75
P/E Ratio
$28.14
$144.84
Revenue Growth
N/A
37.13
52 Week Low
$45.96
$60.11
52 Week High
$66.78
$156.00

Technical Indicators

Market Signals
Indicator
FBNC
TMDX
Relative Strength Index (RSI) 60.09 67.21
Support Level $62.13 $66.64
Resistance Level $66.18 $152.95
Average True Range (ATR) 1.09 4.17
MACD 0.13 0.92
Stochastic Oscillator 81.09 92.12

Price Performance

Historical Comparison
FBNC
TMDX

About FBNC First Bancorp

First Bancorp is a bank holding company. The company is engaged in providing commercial and consumer banking services, mortgage lending, SBA lending, accounts receivable financing, and investment advisory services.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: